Cargando…

Vedolizumab Immunogenicity With Long‐Term or Interrupted Treatment of Patients With Inflammatory Bowel Disease

Patients in the GEMINI 1 or 2 study (NCT00790933; Eudra CT2008‐002784‐14) with ulcerative colitis or Crohn disease had low immunogenicity rates after vedolizumab treatment for up to 52 weeks. We report immunogenicity rates from the GEMINI long‐term safety (LTS) study using a new drug‐tolerant electr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wyant, Timothy, Yang, Lili, Lirio, Richard A., Rosario, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Editor's Choice: Therapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456828/ https://www.ncbi.nlm.nih.gov/pubmed/33908636 http://dx.doi.org/10.1002/jcph.1877

Ejemplares similares

Long‐term safety of vedolizumab for inflammatory bowel disease
por: Loftus, Edward V., et al.
Publicado: (2020)

Influence of Prednisone on Inflammatory Biomarkers in Community‐Acquired Pneumonia: Secondary Analysis of a Randomized Trial
por: Raess, Natalie, et al.
Publicado: (2021)

Mate choice in sticklebacks reveals that immunogenes can drive ecological speciation
por: Andreou, Demetra, et al.
Publicado: (2017)

Long-term efficacy, safety, and tolerability of a subcutaneous immunoglobulin 16.5% (cutaquig(®)) in the treatment of patients with primary immunodeficiencies
por: Kobayashi, Roger H, et al.
Publicado: (2022)

A Review of the Clinical Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Vedolizumab
por: Rosario, Maria, et al.
Publicado: (2017)

Long‐term labour market and economic consequences of school exclusions in England: Evidence from two counterfactual approaches
por: Madia, Joan E., et al.
Publicado: (2022)

Normocalcaemic, vitamin D‐sufficient hyperparathyroidism – high prevalence and low morbidity in the general population: A long‐term follow‐up study, the WHO MONICA project, Gothenburg, Sweden
por: Kontogeorgos, Georgios, et al.
Publicado: (2015)

Risk–benefit and cost–benefit ratio in headache treatment
por: Pini, L. A., et al.
Publicado: (2005)

Assessment of Vedolizumab Disease‐Drug‐Drug Interaction Potential in Patients With Inflammatory Bowel Diseases
por: Sun, Wan, et al.
Publicado: (2020)

Citrobacter rodentium induces rapid and unique metabolic and inflammatory responses in mice suffering from severe disease
por: Carson, Danielle, et al.
Publicado: (2019)

Comparison of the ELISA and ECL Assay for Vedolizumab Anti-drug Antibodies: Assessing the Impact on Pharmacokinetics and Safety Outcomes of the Phase 3 GEMINI Trials
por: Wyant, Timothy, et al.
Publicado: (2020)

Long noncoding RNA Crnde attenuates cardiac fibrosis via Smad3‐Crnde negative feedback in diabetic cardiomyopathy
por: Zheng, Dezhi, et al.
Publicado: (2019)

Vedolizumab Is Safe in Elderly Veteran Patients With Inflammatory Bowel Disease
por: Leung, Kenneth, et al.
Publicado: (2021)

MOSPD2 is a therapeutic target for the treatment of CNS inflammation
por: Yacov, N., et al.
Publicado: (2020)

Acceptability and safety of thermal ablation for the treatment of precancerous cervical lesions in Honduras
por: Sandoval, Manuel, et al.
Publicado: (2019)

SARS-CoV-2 vaccine responses following CD20-depletion treatment in patients with haematological and rheumatological disease: a West Midlands Research Consortium study
por: Shields, Adrian M, et al.
Publicado: (2021)

Computational analysis of flow conditions in hydrodynamic cavitation generator for water treatment processes
por: Gostiša, Jurij, et al.
Publicado: (2022)

Clinical Characteristics and Radiologic Features of Immunocompromised Patients With Pauci-Bacillary Pulmonary Tuberculosis Receiving Delayed Diagnosis and Treatment
por: Park, Joung Ha, et al.
Publicado: (2019)

Mycobacterium leprae intracellular survival relies on cholesterol accumulation in infected macrophages: a potential target for new drugs for leprosy treatment
por: Mattos, Katherine A, et al.
Publicado: (2014)

Notch signalling is a potential resistance mechanism of progenitor cells within patient‐derived prostate cultures following ROS‐inducing treatments
por: Packer, John R., et al.
Publicado: (2019)

Pathogen–host reorganization during Chlamydia invasion revealed by cryo-electron tomography
por: Nans, Andrea, et al.
Publicado: (2014)

Establishing the prevalence of common tissue‐specific autoantibodies following severe acute respiratory syndrome coronavirus 2 infection
por: Richter, Alex G., et al.
Publicado: (2021)

Systematic analysis of Plasmodium myosins reveals differential expression, localisation, and function in invasive and proliferative parasite stages
por: Wall, Richard J., et al.
Publicado: (2019)

The effect of improving solid waste collection on waste disposal behaviour and exposure to environmental risk factors in urban low‐income communities in Pakistan
por: Schmidt, Wolf‐Peter, et al.
Publicado: (2022)

Real-World Effectiveness of Vedolizumab Dose Escalation in Patients With Inflammatory Bowel Disease: A Systematic Literature Review
por: Patel, Dipen, et al.
Publicado: (2022)

Vedolizumab in the treatment of inflammatory bowel disease: evolving paradigms
por: Crooks, Benjamin, et al.
Publicado: (2020)

Is Vedolizumab Truly Gut Selective? It May Not Affect the Immunogenicity of Vaccines in Patients With Inflammatory Bowel Disease
por: Lee, Alexander S, et al.
Publicado: (2020)

The Immunogenicity of the Influenza, Pneumococcal, and Hepatitis B Vaccines in Patients With Inflammatory Bowel Disease Treated With Vedolizumab
por: Harrington, Jill E, et al.
Publicado: (2020)

Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UK
por: Shields, Adrian M, et al.
Publicado: (2022)

Individual risk assessment and information technology to optimise screening frequency for diabetic retinopathy by Aspelund et al. (2011) Diabetologia 54:2525–2532
por: McGhee, Sarah, et al.
Publicado: (2012)

Host carbon sources modulate cell wall architecture, drug resistance and virulence in a fungal pathogen
por: Ene, Iuliana V, et al.
Publicado: (2012)

The safety of using anti-VEGF: Is there strength in numbers? Curtis LH, Hammill BG, Schulman KA, Cousins SW (2010) Risks of mortality, myocardial infarction, bleeding, and stroke associated with therapies for age-related macular degeneration. Arch Ophthalmol 128(10):1273–1279
por: Wong, David, et al.
Publicado: (2011)

The study of flow diversion effects on aneurysm using multiple enterprise stents and two flow diverters
por: Kojima, Masahiro, et al.
Publicado: (2012)

Use of pipeline flow diverting stents for wide neck intracranial aneurysms: A retrospective institutional review
por: Agarwal, Abhishek, et al.
Publicado: (2014)

Complication avoidance in transcallosal transforaminal approach to colloid cysts of the anterior third ventriclen: An analysis of 80 cases
por: Symss, Nigel P., et al.
Publicado: (2014)

Bioluminescence imaging of chronic Trypanosoma cruzi infections reveals tissue-specific parasite dynamics and heart disease in the absence of locally persistent infection
por: Lewis, Michael D, et al.
Publicado: (2014)

Somadril and edgework in South Sulawesi
por: Hardon, Anita P., et al.
Publicado: (2014)

Automated fluorescence lifetime imaging plate reader and its application to Förster resonant energy transfer readout of Gag protein aggregation
por: Alibhai, Dominic, et al.
Publicado: (2013)

Improving on-time start for iMRI neurosurgeries
por: Ghadiali, Natascha Fherzinah Rustom, et al.
Publicado: (2013)

Effect of surgical clipping versus endovascular coiling on recovery from oculomotor nerve palsy in patients with posterior communicating artery aneurysms: A retrospective comparative study and meta-analysis
por: Khan, S. A., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_rmm3fsa9k4e6q36g80magrt58l